bleomycetin has been researched along with Animal Mammary Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Du, YB; Ge, ZJ; Gong, JH; Li, Y; Liu, XJ; Shan, CK; Wang, YX; Zhai, XT; Zhen, YS | 1 |
1 other study(ies) available for bleomycetin and Animal Mammary Carcinoma
Article | Year |
---|---|
Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8
Topics: Animals; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Animal; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Programmed Cell Death 1 Receptor; Tumor Microenvironment | 2021 |